CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

Expedited IND Pilot Program Educational Webinar for Stakeholders - 08/06/2026

Neutral
AI Analysis

Summary

FDA is hosting an educational webinar on a proposed Expedited Investigational New Drug pilot program designed to accelerate development timelines from drug identification to first-in-human clinical trials.

Importance:1/10
Sentiment:
0.00
FDAINDRegulatoryEducational Webinar
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 5, 2026 8:38 PM

Read Original